Mark Lappe
Director, Repros Therapeutics.
Companies
- Inhibrx Biosciences, Inc.Board member May 24, 2024 to now1
- Inhibrx Biosciences, Inc.Chief executive officer May 24, 2024 to now1
- Inhibrx, Inc.Board member Aug 18, 2020 to May 30, 20242
- Inhibrx, Inc.Chief executive officer Aug 18, 2020 to May 30, 20242
- Repros TherapeuticsBoard member Oct 1, 2008 to May 22, 20093
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Inhibrx Biosciences, Inc. INBX54,865 shares4$4.9M at $89.06Sep 28, 2026
- Inhibrx, Inc.0 shares5May 30, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- Sep 28, 2026Bought 3,000 shares at $101.70 of Inhibrx Biosciences, Inc.4
- Sep 28, 2026Bought 1,500 shares at $98.88 of Inhibrx Biosciences, Inc.4
- Sep 25, 2026Bought 2,176 shares at $99.60 of Inhibrx Biosciences, Inc.4
- Sep 25, 2026Bought 3,324 shares at $98.87 of Inhibrx Biosciences, Inc.4
- Sep 8, 2026Bought 9,681 shares at $112.28 of Inhibrx Biosciences, Inc.6
- Sep 8, 2026Bought 1,219 shares at $111.88 of Inhibrx Biosciences, Inc.6
- Sep 8, 2026Bought 500 shares at $108.24 of Inhibrx Biosciences, Inc.6
- Sep 8, 2026Bought 1,100 shares at $107.12 of Inhibrx Biosciences, Inc.6
- Sep 8, 2026Bought 6,605 shares at $100.64 of Inhibrx Biosciences, Inc.6
- Sep 8, 2026Bought 5,895 shares at $99.29 of Inhibrx Biosciences, Inc.6
- Sep 16, 2024Bought 13,037 shares at $17.13 of Inhibrx Biosciences, Inc.7
- Sep 12, 2024Bought 26,963 shares at $15.05 of Inhibrx Biosciences, Inc.7
- Sep 10, 2024Bought 8,500 shares at $15.19 of Inhibrx Biosciences, Inc.8
- Sep 9, 2024Bought 9,500 shares at $15.21 of Inhibrx Biosciences, Inc.8
- Sep 6, 2024Bought 26,000 shares at $15.29 of Inhibrx Biosciences, Inc.8
- Sep 3, 2024Bought 4,712 shares at $16.31 of Inhibrx Biosciences, Inc.9
- Sep 3, 2024Bought 15,288 shares at $15.66 of Inhibrx Biosciences, Inc.9
- Aug 30, 2024Bought 10,000 shares at $14.02 of Inhibrx Biosciences, Inc.9
- Aug 29, 2024Bought 10,000 shares at $14.03 of Inhibrx Biosciences, Inc.9
- Aug 21, 2024Bought 12,945 shares at $12.93 of Inhibrx Biosciences, Inc.10
- Aug 20, 2024Bought 27,055 shares at $12.97 of Inhibrx Biosciences, Inc.10
- May 30, 2024Returned to company 59,462 shares at $30.00 of Inhibrx, Inc.5
- May 30, 2024Returned to company 500,000 shares at $30.00 of Inhibrx, Inc.5
- May 30, 2024Returned to company 2,486,192 shares at $30.00 of Inhibrx, Inc.5
- May 29, 2024Granted 14,865 shares of Inhibrx Biosciences, Inc.11
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARInhibrx, Inc., Board member
- 3SEC EDGARRepros Therapeutics, Board member
- 4
- 5
- 6SEC EDGARForm 4 filed Sep 8, 2026
- 7SEC EDGARForm 4 filed Sep 16, 2024
- 8SEC EDGARForm 4 filed Sep 10, 2024
- 9SEC EDGARForm 4 filed Sep 3, 2024
- 10SEC EDGARForm 4 filed Aug 22, 2024
- 11SEC EDGARForm 4 filed May 30, 2024